Zydus Lifesciences shares were trading flat on October 18 after the company received final approval to manufacture ...

ICMR partners with Zydus Lifesciences for Desidustat phase-2 trials in sickle cell disease patients, aiming for innovative ...

The Delhi High Court division bench has allowed Zydus Lifesciences to sell its breast cancer drug Sigrima amidst accusations ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Fludrocortisone Acetate Tablets USP, 0.1 mg (USRLD: Florinef Tablets, 0.1 mg).

Delhi HC reinstates injunction on Zydus, halting sale of breast cancer drug Sigrima: Shardul Nautiyal, Mumbai Friday, October 18, 2024, 18:15 Hrs [IST] The Division Bench of the D ...

The ICMR has formalized a Memorandum of Agreement (MoA) with Zydus for a Phase IIa double-blind, randomized, ...

Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Fludrocortisone Acetate tablets USP, 0.1 mg.

The Indian Council of Medical Research (ICMR) on Monday announced a partnership with domestic pharma giant Zydus Lifesciences ...

Macquarie rates Bajaj Auto as neutral citing disappointing gross margins, while Jefferies is optimistic on KEI Industries, ...

On Sept. 13, Zydus Lifesciences signed a pact with US-based Viwit Pharmaceuticals for two MRI injectables and contrast agents. The pact has been inked for gadobutrol injection, a generic version of ...

Zydus Lifesciences received the FDA go-ahead to manufacture paliperidone extended-release tablets, 1.5 mg, 3 mg, 6 mg, and 9 ...